|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-7-5
|
|
pubmed:abstractText |
Treatment with intravenous immunoglobulin (IVIG) is considered a safe therapy for patients with primary antibody deficiencies (PADs), whilst adverse effects have been frequently reported. Meantime behavioral disorders reactions have not been reported yet. In this study, we describe for the first time a group of patients with PADs, who were under IVIG therapy and experienced some behavioral disorders.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1099-1077
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2010 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
419-22
|
|
pubmed:meshHeading |
pubmed-meshheading:20589928-Adolescent,
pubmed-meshheading:20589928-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:20589928-Child,
pubmed-meshheading:20589928-Child, Preschool,
pubmed-meshheading:20589928-Child Behavior Disorders,
pubmed-meshheading:20589928-Female,
pubmed-meshheading:20589928-Humans,
pubmed-meshheading:20589928-Immunoglobulins, Intravenous,
pubmed-meshheading:20589928-Immunologic Deficiency Syndromes,
pubmed-meshheading:20589928-Immunologic Factors,
pubmed-meshheading:20589928-Male,
pubmed-meshheading:20589928-Psychiatric Status Rating Scales,
pubmed-meshheading:20589928-Severity of Illness Index
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Behavior abnormality following intravenous immunoglobulin treatment in patients with primary antibody deficiencies.
|
|
pubmed:affiliation |
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
|
|
pubmed:publicationType |
Journal Article
|
